A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
Medical risks of obesity include high blood pressure, type 2 diabetes, and cardiovascular diseases. Additionally, obesity has been associated...
Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still,...
On Friday, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic olaparib (Lynparza) for treating certain...
A diverse group of about 220 physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research...
This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in...
As 2017 draws to a close, I’ve been reflecting on another year in cancer research. As Chief Executive Officer...
While Cancer Research Catalyst covers the spectrum of cancer research news, we weren’t surprised to discover that the hottest...
When we think about “cancer scientists,” we typically conjure images of physicians treating their patients or biologists analyzing cells...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical...